The top explosive growth stock I will be talking about is $HIMS (Hims and hers health). This is the only mid cap explosive growth stock I own and for good reason.
What is $HIMS?
Hims and Hers Health is a Telehealth company offering personalized treatments for a variety of problems, including hair loss, ED (erectile dysfunction), anxiety and depression, skincare, birth control, and most notably, a comprehensive weight loss program using GLP-1 injections (similar to Ozempic) or oral medications. They deliver their products directly to your house, with discreet options available.
What’s truly revolutionary about this is how they’ve made getting treatment convenient, private, and fast. They’ve also helped de-stigmatize certain health conditions like hair loss, making it simple and non-judgmental to receive treatment right at your door.

Exponential Financial Growth
To backup and prove this business model and solidify $HIMS as an explosive growth stock is incredible growth in Free cash flow where they grew 367% year-over-year, revenue where they grew 95% year-over-year and total subscribers where they grew 43% year-over-year.

This chart displays the explosive upwards growth of $HIMS revenue.

This chart displays explosive upwards growth of $HIMS total subscribers.
Any Obstacles?
The ongoing shortage of GLP-1s is due to overwhelming demand. However, the $HIMS CEO recently shared some insights during an interview.
He used a powerful analogy to explain the situation:
“It’s like a blockbuster movie—the GLP-1s—but it’s not available on Netflix. Customers want to stream it because it’s easy, amazing, and they love it. But the industry insists on pushing it through theaters instead.”
In essence, $HIMS is like Netflix. Everyone wants to stream the latest hit (GLP-1s), but the industry sticks to outdated distribution (theaters). $HIMS offers a smoother, more modern solution. Just as Netflix disrupted entertainment, $HIMS is ready to transform healthcare delivery.
Conclusion
$HIMS is a strong company with an impressive management team and solid fundamentals. Its growth trajectory is clear, making it a high-conviction stock. Despite the current tariff-driven sell-off, I will confidently buy on the dip.
Hope you enjoyed!
P.S. Want to learn how to navigate turbulent markets such as the one we are in today? Check out my quick guide—click here to read it!